Results 61 to 70 of about 7,446,673 (360)

Analisis Pengaruh Profitabilitas, Likuiditas dan Solvabilitas Terhadap Return Saham Syariah dengan Risiko Investasi Sebagai Variabel Intervening

open access: yesMedina-Te, 2022
This study aims to determine whether or not the effect of profitability, liquidity and solvency on Islamic stock returns, the effect of profitability, liquidity and solvency on investment risk, the effect of investment risk on Islamic stock returns and ...
Desi Ayu Lestari   +2 more
doaj   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

The Funding Liquidity Risk and Bank Risk: A Review on the Islamic and Conventional Banks in Pakistan

open access: yesHamdard Islamicus, 2021
The Prime objective of the current study is to discuss the link between the funding liquidity risk and bank risk for Islamic and conventional of Pakistan.
SAIRA GHULAM HASSAN
doaj   +2 more sources

The predictive performance of liquidity risk

open access: yesCogent Economics & Finance, 2021
This paper assesses the explanatory power of the liquidity-risk-based pricing models relative to the Fama–French three-factor model (FF3) and the extensions to the FF3.
Xiuli Ma, Xindong Zhang
doaj   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Pricing Liquidity Risk with Heterogeneous Investment Horizons [PDF]

open access: yes, 2020
We develop an asset pricing model with stochastic transaction costs and investors with heterogeneous horizons. Depending on their horizon, investors hold different sets of assets in equilibrium.
Beber, A.   +3 more
core   +1 more source

Derivatives pricing with liquidity risk

open access: yesJournal of futures markets, 2019
This paper develops a novel, general derivative pricing model which introduces a liquidity risk factor. The model variants we outline offer a sufficient degree of flexibility so as to enable the valuation of various types of derivative classes including ...
Yongmin Zhang   +2 more
semanticscholar   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy